PHLN statement on using saliva as a respiratory specimen for SARS-CoV-2 testing

We aim to provide documents in an accessible format. If you're having problems using a document with your accessibility tools, please contact us for help.

Publication date: 
15 February 2021
Last updated: 
10 June 2021
Publication type: 
Fact sheet
Intended audience: 
Health sector

This document states the PHLN's position on the use of saliva as an alternative specimen for the diagnosis of SARS-CoV-2.